Nyxoah (NASDAQ:NYXH) Issues Earnings Results

Nyxoah (NASDAQ:NYXH) released its quarterly earnings data on Tuesday. The company reported ($0.43) EPS for the quarter, topping analysts’ consensus estimates of ($0.54) by $0.11, FiscalAI reports. The firm had revenue of $7.38 million during the quarter, compared to the consensus estimate of $7.05 million. Nyxoah had a negative net margin of 884.69% and a negative return on equity of 139.18%.

Nyxoah Stock Performance

NASDAQ NYXH traded down $0.26 on Tuesday, hitting $3.07. The stock had a trading volume of 24,489 shares, compared to its average volume of 48,456. Nyxoah has a one year low of $2.76 and a one year high of $8.64. The company has a quick ratio of 1.16, a current ratio of 1.25 and a debt-to-equity ratio of 0.37. The stock has a market cap of $118.99 million, a price-to-earnings ratio of -1.15 and a beta of 1.56. The company’s 50-day moving average is $3.25 and its two-hundred day moving average is $4.28.

Analyst Upgrades and Downgrades

NYXH has been the topic of a number of recent research reports. Stifel Nicolaus reissued a “hold” rating and issued a $5.00 target price (down from $8.00) on shares of Nyxoah in a report on Tuesday. Weiss Ratings cut shares of Nyxoah from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 22nd. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $11.00 target price on shares of Nyxoah in a report on Monday, March 23rd. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $8.33.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Bank of America Corp DE boosted its position in Nyxoah by 72.4% during the 2nd quarter. Bank of America Corp DE now owns 7,866 shares of the company’s stock worth $59,000 after acquiring an additional 3,303 shares during the period. Raymond James Financial Inc. boosted its position in Nyxoah by 35.6% during the 3rd quarter. Raymond James Financial Inc. now owns 12,762 shares of the company’s stock worth $59,000 after acquiring an additional 3,353 shares during the period. Deutsche Bank AG boosted its position in Nyxoah by 40.0% during the 4th quarter. Deutsche Bank AG now owns 35,000 shares of the company’s stock worth $161,000 after acquiring an additional 10,000 shares during the period. Citadel Advisors LLC acquired a new position in Nyxoah during the 3rd quarter worth $98,000. Finally, Shay Capital LLC acquired a new position in Nyxoah during the 2nd quarter worth $374,000.

Nyxoah Company Profile

Nyxoah SA, headquartered in Mont-Saint-Guibert, Belgium, is a medical technology company focused on neuromodulation therapies for sleep‐disordered breathing. Established in 2018, the company’s primary offering is the Genio® system, a minimally invasive bilateral hypoglossal nerve stimulator designed to treat moderate to severe obstructive sleep apnea (OSA). By electrically stimulating the genioglossus muscle, the device helps maintain airway patency during sleep, reducing apnea events and improving overall sleep quality.

The Genio system comprises a small, implantable stimulator positioned submentally and an external activation unit worn by the patient.